Hsa-miR-499 polymorphism (rs3746444) and cancer risk: A meta-analysis of 17 case-control studies

Gene

Volumn 509, Issue 2, 2012, Pages 267-272

  Wang, Yang ^a   Yang, Baohong ^a   Ren, Xiubao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Hsa miR 499 rs11614913; Meta analysis; Single nucleotide polymorphism

Indexed keywords

MICRORNA; MICRORNA 449; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; ETHNICITY; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE; HETEROZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; META ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; GENOTYPE; HUMANS; MICRORNAS; NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84866392273     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.08.008     Document Type: Article

References (38)

1. Akkiz H., Bayram S., Bekar A., Akgollu E., Uskudar O. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac. J. Cancer Prev. 2011, 12:3107-3112.
2. Alshatwi A.A., et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One 2012, 7:e30049.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Catucci I., et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum. Mutat. 2010, 31:E1052-E1057.
5. Chen K., Song F., Calin G.A., Wei Q., Hao X., Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008, 29:1306-1311.
6. Chen L.T., Xu S.D., Xu H., Zhang J.F., Ning J.F., Wang S.F. MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Med. Oncol. 2011, 29:1673-1680.
7. Chu H., et al. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 2011, 6:e18108.
8. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
9. Desjardins S., Beauparlant J.C., Labrie Y., Ouellette G., Durocher F. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer. BMC Cancer 2009, 9:181.
10. Egger M., Davey S.G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
11. George G.P., Gangwar R., Mandal R.K., Sankhwar S.N., Mittal R.D. Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol. Biol. Rep. 2011, 38:1609-1615.
12. Hirschhorn J.N., Lohmueller K., Byrne E., Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 2002, 4:45-61.
13. Hu Z., et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 2008, 118:2600-2608.
14. Hu Z., et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 2009, 30:79-84.
15. Ivanovska I., et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 2008, 28:2167-2174.
16. Landgraf P., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
17. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann. Intern. Med. 1997, 127:820-826.
18. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
19. Liu Z., et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010, 116:4753-4760.
20. Lu Y., Thomson J.M., Wong H.Y., Hammond S.M., Hogan B.L. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 2007, 310:442-453.
21. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
22. Min K.T., et al. Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol. Carcinog. 2011, (Epub ahead of print). 10.1002/mc.21849.
23. Mittal R.D., Gangwar R., George G.P., Mittal T., Kapoor R. Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA Cell Biol. 2011, 30:401-406.
24. Okubo M., et al. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 2010, 15:524-531.
25. Pickard M.R., et al. Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer. Breast Cancer Res. 2009, 11:R60.
26. Saunders M.A., Liang H., Li W.H. Human polymorphism at microRNAs and microRNA target sites. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3300-3305.
27. Srivastava K., Srivastava A., Mittal B. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J. Hum. Genet. 2010, 55:495-499.
28. Takamizawa J., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-3756.
29. Tian T., et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1183-1187.
30. Vinci S., et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin. Chem. Lab. Med. 2011, 49:2073-2080.
31. Wang R., Wang Z.X., Yang J.S., Pan X., De W., Chen L.B. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011, 30:2644-2658.
32. Wang J., Bi J., Liu X., Li K., Di J., Wang B. Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol. Biol. Rep. 2012, 39:4571-4579.
33. Whitehead A., Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat. Med. 1991, 10:1665-1677.
34. Xiang Y., Fan S., Cao J., Huang S., Zhang L.P. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol. Biol. Rep. 2012, 39:7019-7023.
35. Xu W., et al. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One 2011, 6:e20471.
36. Yang W., et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 2006, 13:13-21.
37. Zhou B., et al. Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol. Carcinog. 2011, 50:499-505.
38. Zhou J., et al. Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol. 2012, 31:524-530.